Paloma Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,873
Closed -$4.73M 1500
2024
Q1
$4.73M Buy
35,873
+18,573
+107% +$2.32M 0.25% 91
2023
Q4
$2.11M Buy
17,300
+13,100
+312% +$1.46M 0.08% 266
2023
Q3
$471K Buy
+4,200
New +$533K 0.02% 491
2023
Q2
Sell
-6,500
Closed -$840K 963
2023
Q1
$840K Buy
+6,500
New +$816K 0.03% 400
2022
Q4
Sell
-5,500
Closed -$575K 1191
2022
Q3
$575K Buy
5,500
+3,500
+175% +$384K 0.03% 442
2022
Q2
$210K Buy
+2,000
New +$237K 0.01% 851
2022
Q1
Sell
-19,570
Closed -$2.41M 2306
2021
Q4
$2.41M Buy
19,570
+15,862
+428% +$2.08M 0.04% 397
2021
Q3
$527K Buy
+3,708
New +$545K 0.01% 532
2021
Q1
Sell
-10,094
Closed -$1.51M 2410
2020
Q4
$1.51M Buy
+10,094
New +$1.43M 0.04% 445
2020
Q3
Sell
-515
Closed -$60K 2532
2020
Q2
$60K Buy
+515
New +$59.3K ﹤0.01% 1973
2019
Q3
Sell
-3,502
Closed -$400K 2335
2019
Q2
$400K Buy
+3,502
New +$410K 0.01% 1150
2018
Q3
Sell
-7,210
Closed -$780K 2000
2018
Q2
$780K Buy
+7,210
New +$785K 0.01% 824

Other funds holding ZBH

Paloma Partners's ZBH Position: Q2 2024 in Review

Paloma Partners sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 482 shares — an estimated $63.6K sold.

Paloma Partners first reported a position in ZBH in Q2 2014 and held it in 30 quarters. The position peaked at $13.1M in Q4 2021. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Paloma Partners reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Paloma Partners sold 482 Zimmer Biomet shares in Q2 2024, an estimated $63.6K.
  • Paloma Partners first reported a position in Zimmer Biomet in Q2 2014 and held it in 30 quarters.
  • Paloma Partners's Zimmer Biomet position peaked at $13.1M in Q4 2021.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.